Search results
16 paź 2024 · Hormone-releasing intrauterine devices (IUDs) are associated with a slightly higher risk of breast cancer among young women, according to a large new Danish study. IUDs are among the most...
16 paź 2024 · By Nina Agrawal. Published Oct. 16, 2024 Updated Oct. 17, 2024. A study published Wednesday found that women using contraceptive intrauterine devices that deliver a certain hormone are at increased...
6 dni temu · CNN — A new study adds to a growing set of evidence that women who use hormonal birth control have higher rates of breast cancer, but experts have stressed that the overall risk remains low.
1 paź 2024 · Survival. Breast cancer survival varies widely by stage at diagnosis, molecular subtype, and other clinicopathologic features. Stage at diagnosis is the strongest prognostic indicator, with the 5-year relative survival rate ranging from >99% for localized stage disease to 87% for regional stage and 32% for distant stage disease.
4 dni temu · There are two different ways researchers express risk: "relative" and "absolute" risks. Here, the "relative" risk increase was about 30% for women using the IUDs for up to five years, 40% after 5 ...
6 dni temu · During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use, reaching 80%...
8 mar 2022 · Levonorgestrel intrauterine sustained release system (LNG-IUS) is an intrauterine hormonal contraceptive device. Breast cancer (BC) was the most common type of cancer in women in the world in 2020. The relationship between LNG-IUS and BC is controversial.
